University of Pittsburg Cancer Institute — Pittsburgh, Pennsylvania

University of Pittsburg Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pittsburg Cancer Institute has participated in 2 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Metastatic Liver Cancer, Ocular Melanoma.

Sponsors: Cyclacel Pharmaceuticals, Inc., Delcath Systems Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburg Cancer Institute?

University of Pittsburg Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburg Cancer Institute conducted?

University of Pittsburg Cancer Institute has 2 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Metastatic Liver Cancer, Ocular Melanoma.

Is University of Pittsburg Cancer Institute accredited by Crixeo Health?

University of Pittsburg Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburg Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.